{"status":"OK","data":{"advertisement":{"id":198862,"title":"Zapytanie ofertowe nr 1/2023 Badanie farmakokinetyki prototypu leku PNI19","partial_offer_allowed":false,"publication_date":"2023-03-24","submission_deadline":"2023-04-11 23:59:59","planned_sign_date":null,"supplementary_orders":null,"terms_of_contract_change":"Szczeg\u00f3\u0142owe informacje zawarte zosta\u0142y w za\u0142\u0105czonym pliku \"Zapytanie ofertowe\" - stanowi\u0105cym za\u0142. nr 2 do niniejszego og\u0142oszenia.","created_at":"2023-03-24 09:19:17","modified_at":"2023-04-12 00:00:03","contact_persons":[{"id":50120,"forename":"Dawid","surname":"Chabowski","phone_number":"510 672 177","email":"dawid@auxiliuspharma.com","created_by":null,"created_at":"2023-06-19 12:53:36","modified_at":"2023-06-19 12:53:36","modified_by":null}],"orders":[{"id":329170,"estimated_value":null,"order_items":[{"id":373532,"description":"1. Przedmiotem zam\u00f3wienia jest wykonanie 1 (jednego) lub 2 (dw\u00f3ch) bada\u0144 farmakokinetyki prototypu leku wyprodukowanego dla Auxilius Pharma w standardzie GMP. Pomi\u0119dzy tymi badaniami Auxilius Pharma przewiduje optymalizacj\u0119 leku PNI19, maj\u0105c\u0105 na celu wprowadzenie do formulacji leku zmian okre\u015blonych na podstawie wynik\u00f3w Pierwszego Badania. Decyzja o rozpocz\u0119ciu Drugiego Badania uzale\u017cniona b\u0119dzie od pomy\u015blnie przeprowadzonej reformulacji leku.\n2. Szczeg\u00f3\u0142owe informacje zawarte zosta\u0142y w za\u0142\u0105czonym pliku \"Zapytanie ofertowe\" - stanowi\u0105cym za\u0142. nr 2 do niniejszego og\u0142oszenia.","warranty_period":"Nie dotyczy","cpv_items":[{"id":8512,"code":"73000000-2","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe oraz pokrewne us\u0142ugi doradcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":null,"poviat":null,"commune":null,"locality":null,"created_by":null,"created_at":"2023-03-24 09:19:17","modified_at":"2023-03-24 09:19:17","modified_by":null,"id":420760,"type":{"id":2,"name":"ca\u0142a Polska"},"group_uuid":"939a29a3-e530-4a6c-ba7b-3b7aa2b26f32"}],"participation_conditions":[{"id":1016010,"description":"Szczeg\u00f3\u0142owe informacje zawarte zosta\u0142y w za\u0142\u0105czonym pliku \"Zapytanie ofertowe\" - stanowi\u0105cym za\u0142. nr 2 do niniejszego og\u0142oszenia.","type":{"id":2,"name":"Wiedza i do\u015bwiadczenie"},"created_by":null,"created_at":"2023-03-24 09:19:17","modified_at":"2023-03-24 09:19:17","modified_by":null,"group_uuid":"5960ebb7-a46f-475b-8d82-587902fac894"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-03-24 09:19:17","modified_at":"2023-03-24 09:19:17","modified_by":null,"group_uuid":"d483ba02-37ab-4078-b363-b5dce9453197"}],"evaluation_criteria":[{"id":572090,"price_criterion":true,"description":"Cena netto (waga kryterium: 80 pkt.)\nSzczeg\u00f3\u0142owe informacje zawarte zosta\u0142y w za\u0142\u0105czonym pliku \"Zapytanie ofertowe\" -stanowi\u0105cym za\u0142. nr 2 do niniejszego og\u0142oszenia.","created_by":null,"created_at":"2023-03-24 09:19:17","modified_at":"2023-03-24 09:19:17","modified_by":null,"group_uuid":"c4020cfc-bf4d-4589-b2f6-3de05d27f20d"}],"is_variant":false,"title":"Badanie farmakokinetyki prototypu leku PNI19","order_node":{"id":247756},"created_by":null,"created_at":"2023-03-24 09:19:17","modified_at":"2023-03-24 09:19:17","modified_by":null}],"created_by":{"id":3133,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"AUXILIUS PHARMA Sp\u00f3\u0142ka z ograniczon\u0105 odpowiedzialno\u015bci\u0105","identification_number_type":"nip","identification_number":"5252767695","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"\u015ar\u00f3dmie\u015bcie","locality":"Warszawa","created_by":{"id":3133,"contact_persons":[]},"created_at":"2023-03-24 09:19:17","modified_at":"2023-03-24 09:19:17","modified_by":{"id":3133,"contact_persons":[]},"id":517290,"street":"Ho\u017ca ","number_description":"86","postcode":"00-682"},"created_by":{"id":3133,"contact_persons":[]},"created_at":"2023-03-24 09:19:17","modified_at":"2023-03-24 09:19:17","modified_by":{"id":3133,"contact_persons":[]},"id":199311},"advertisement":{"id":149898,"number":"2023-3133-149898","publication_date":"2023-03-10","created_by":{"id":3133,"contact_persons":[]},"created_at":"2023-03-10 16:28:28","modified_at":"2023-04-12 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[196244,196418,198862],"enrollment":{"id":36174,"name":"Badania innowacyjnej formulacji leku stosowanego w leczeniu przewlek\u0142ej choroby wie\u0144cowej","number":"001/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-001/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-03-10 15:05:13","modified_at":"2023-03-10 15:05:13","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":196244,"publication_date":"2023-03-10"},"id":936368,"name":"Za\u0142.2 Zapytanie ofertowe","file":{"id":1044168,"name":"AP_Za\u0142.2_Zapytanie_of_Pilot_PK.pdf","created_at":"2023-03-24 09:19:17","created_by":{"forename":"AUXILIUS PHARMA","surname":"sp. z o.o."},"uri":"/api/files/1044168"},"group_uuid":"6453a269-d6ef-44b4-9b45-573cf6439ecf"},{"origin":{"id":196244,"publication_date":"2023-03-10"},"id":936369,"name":"Za\u0142.1 Formularz ofertowy","file":{"id":1044169,"name":"AP Za\u0142.1_Formularz Of_PilotPK.docx","created_at":"2023-03-24 09:19:17","created_by":{"forename":"AUXILIUS PHARMA","surname":"sp. z o.o."},"uri":"/api/files/1044169"},"group_uuid":"1a2c3f23-034a-4581-9dcf-0fadb253b34d"},{"origin":{"id":196418,"publication_date":"2023-03-13"},"id":937389,"name":"Za\u0142.3 Zakres zmian","file":{"id":1045295,"name":"AP Za\u0142.3 Zakres_zmian.pdf","created_at":"2023-03-24 09:19:17","created_by":{"forename":"AUXILIUS PHARMA","surname":"sp. z o.o."},"uri":"/api/files/1045295"},"group_uuid":"536f1f3c-6354-46c9-9716-c4cd4b4a4662"},{"origin":{"id":198862,"publication_date":"2023-03-24"},"id":952181,"name":"Request for Proposal_Pilot_PK_nr1_ENG","file":{"id":1061513,"name":"Request for Proposal_Pilot_PK_nr1_ENG.pdf","created_at":"2023-03-24 09:16:29","created_by":{"forename":"AUXILIUS PHARMA","surname":"sp. z o.o."},"uri":"/api/files/1061513"},"group_uuid":"c7ee9bd1-70b3-42cf-8541-c39ce9ff739c"},{"origin":{"id":198862,"publication_date":"2023-03-24"},"id":952182,"name":"Attachment nr 1 - Proposal Form_Pilot_PK_ENG.","file":{"id":1061516,"name":"Attachment nr 1 - Proposal Form_Pilot_PK_ENG.DOCX","created_at":"2023-03-24 09:17:44","created_by":{"forename":"AUXILIUS PHARMA","surname":"sp. z o.o."},"uri":"/api/files/1061516"},"group_uuid":"3fbe428c-7264-4637-9c8b-2c3235017f6a"},{"origin":{"id":198862,"publication_date":"2023-03-24"},"id":952183,"name":"AP Pilot_PK_Inf_wersja_ang","file":{"id":1061517,"name":"AP Pilot_PK_Inf_wersja_ang.pdf","created_at":"2023-03-24 09:17:57","created_by":{"forename":"AUXILIUS PHARMA","surname":"sp. z o.o."},"uri":"/api/files/1061517"},"group_uuid":"6579cfa8-3395-48b1-8003-2cf4329b1730"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}